Could a simple numbing shot replace general anesthesia for prostate cancer treatment?

NCT ID NCT07412275

Not yet recruiting Symptom relief Sponsor: Koelis Source: ClinicalTrials.gov ↗

First seen Feb 18, 2026

Summary

This study looks at whether a focused microwave treatment for localized prostate cancer can be performed using only local anesthesia (numbing the area) instead of general anesthesia or deep sedation. Twenty patients will undergo the procedure, and researchers will measure how often it can be completed without switching to stronger anesthesia. They will also check safety, patient satisfaction, and pain medication use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hôpital Cochin Port Royal

    Paris, 75014, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Institut Jules Bordet

    Brussels, 1070, Belgium

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

microwave ablation and local anesthesia (lidocaine hydrochloride)

What this could lead to

If successful, this approach could make prostate cancer treatment more comfortable and accessible by avoiding general anesthesia.

What could go wrong

This is a very small feasibility study (20 people) that hasn't started yet, so it's too early to know if it will work or be widely adopted.

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.